| Exec date | Filing date | Company | Role | Signal | Confidence | Shares | % of shares | Under plan? | Amount (USD) |
|---|---|---|---|---|---|---|---|---|---|
| Dec 17, 2025 | Dec 19, 2025 | Sionna Therapeutics, Inc. | Director | Sell | 47.5 | -1,875 | -0.05% | ✗ | $83.4K |
| Nov 24, 2025 | Nov 26, 2025 | Sionna Therapeutics, Inc. | Director | Sell | 17.5 | -108,073 | -2.92% | ✗ | $4.8M |
| Mar 24, 2025 | Mar 26, 2025 | Disc Medicine, Inc. | Director | Sell | 37.5 | -5,738 | -0.40% | ✗ | $310.5K |
| Mar 19, 2025 | Mar 21, 2025 | Disc Medicine, Inc. | Director | Sell | 17.5 | -52,429 | -1.21% | ✗ | $2.8M |
| Mar 10, 2025 | Mar 12, 2025 | Disc Medicine, Inc. | Director | Sell | 15.0 | -312,384 | -3.87% | ✗ | $17M |
| Feb 10, 2025 | Feb 10, 2025 | Sionna Therapeutics, Inc. | Director | Buy | 100.0 | +550,000 | 17.43% | ✗ | $9.9M |
| Oct 15, 2024 | Oct 17, 2024 | Upstream Bio, Inc. | Director | Buy | 100.0 | +825,000 | 16.95% | ✗ | $14M |
| Jun 17, 2024 | Jun 20, 2024 | Disc Medicine, Inc. | Director | Buy | 92.5 | +83,334 | 4.90% | ✗ | $3M |
| Jan 30, 2024 | Jan 31, 2024 | ArriVent BioPharma, Inc. | Director | Buy | 100.0 | +444,444 | 17.21% | ✗ | $8M |
| Dec 18, 2023 | Dec 20, 2023 | Disc Medicine, Inc. | Director | Sell | 47.5 | -1,724 | -0.10% | ✗ | $102.1K |
| Dec 14, 2023 | Dec 15, 2023 | Disc Medicine, Inc. | Director | Sell | 15.0 | -433,200 | -20.29% | ✗ | $24.6M |
| Dec 12, 2023 | Dec 14, 2023 | Disc Medicine, Inc. | Director | Sell | 16.3 | -134,200 | -2.11% | ✗ | $7.9M |
| Feb 15, 2023 | Feb 17, 2023 | Disc Medicine, Inc. | Director | Buy | 95.0 | +108,696 | 5.03% | ✗ | $2.5M |
| Dec 29, 2021 | Dec 30, 2021 | Janux Therapeutics, Inc. | Director | Sell | 20.0 | -40,400 | -1.60% | ✗ | $820.1K |
| Dec 21, 2021 | Dec 23, 2021 | Janux Therapeutics, Inc. | Director | Sell | 17.5 | -119,400 | -4.51% | ✗ | $2.3M |
| Jun 15, 2021 | Jun 16, 2021 | Janux Therapeutics, Inc. | Director | Buy | 100.0 | +705,853 | 30.20% | ✗ | $12M |